Patients Seeking AD Treatment Finding Value in White-Glove Service of Local Pharmacies
White-glove service provided by local pharmacies can increase convenience for patients navigating atopic dermatitis (AD) treatment options.
Initiatives to Reduce Maternal Mortality: Part 1
Sharon Deans, MD, MPH, MBA, and Roxie Cannon Wells, MD, discuss disparities affecting maternal mortality rates.
Disparities Related to Morbidity and Mortality in Maternal Health
Ensuring appropriate pre-pregnancy through postnatal care is critical for optimal health of mother and child.
Examining Cytokine Release Syndrome
Cytokine release syndrome can limit aggressive RRMM treatment strategies.
RRMM Treatment Regimen Considerations
Panelists discuss relapsed/refractory multiple myeloma treatment regimen strategies.
Overview of Current Vaccine Landscape
The panel measures the significance of an RSV vaccine in relation to other vaccines in circulation.
Populations At Risk for Contracting RSV
Traditionally thought of as a pediatric disease, RSV also affects older patient populations.
Patient-Specific Characteristics Driving AD Treatment Regimen
Drs Keegan and Cameron discuss patient-specific considerations for selecting optimal atopic dermatitis treatment strategies.
JAK Inhibitor Usage Benefiting an Array of Dermatological Conditions
Off-label use of JAK inhibitors can prove beneficial in the treatment of several dermatologic conditions.
Racial Disparities Associated With Endometriosis Diagnosis
Soyini Hawkins, MD, MPH, FACOG, drives a conversation regarding the impact of race in diagnosing endometriosis.
Impact of Affordable Care Act on Diagnosis of Uterine Fibroids and Endometriosis
Early detection of uterine fibroids and endometriosis has been powered by the Affordable Care Act, ultimately improving prognosis for patient outcomes.
Bispecific Treatment Options for RRMM
Key opinion leaders dive into the use of bispecific treatment options for RRMM.
Improving Treatment Strategies for Patients with RRMM
Various treatment options for patients with relapsed/refractory MM are discussed.
Complications Associated with RSV
Adam C. Welch, PharmD, MBA, FAPhA, leads a panel discussion surrounding complications related to RSV infection.
Incidence and Prevalence of RSV
A panel of medical experts discuss the prevalence of RSV in adults.
Selecting Appropriate Patient Populations for Ruxolitinib
Dr Butrus leads a discussion on the ideal patient population for treating atopic dermatitis with ruxolitinib.
Ruxolitinib in Treatment of Atopic Dermatitis
The panelists highlight the treatment nature of ruxolitinib, a JAK inhibitor used to treat atopic dermatitis.
Community Engagement Strategies Eliminate Racial and Ethnic Disparities in Patients With Gynecologic Conditions
Medical experts provide insights surrounding efforts to ensure equitable health for women across underserved patient populations.
Creating an Environment of Trust for Underrepresented Populations in Health Care
Derek van Amerongen, MD, MS, leads a panel discussion surrounding disparities currently facing women in health care.
CAR-T Cell Therapy Overview
Dr Matous leads a conversation regarding CAR T-cell therapy for treating multiple myeloma.
Drug Therapies for RRMM Treatment
The panel provides an overview of drug treatment options for patients with RRMM.
Typical Onset of Action to Relieve Itch Associated with Atopic Dermatitis
Managing itch associated with atopic dermatitis is a critical intervention to patient quality of life.
Topical vs Systemic Treatment for AD
Medical experts navigate the selection process for optimal atopic dermatitis treatment strategies from provider and payer perspectives.
Social Determinants of Health Impacting Access to Care for Patients with Cardiovascular Disease
In her closing thoughts, Dr Michos highlights social determinants of health impacting the treatment landscape for patients with cardiovascular disease.
Improving Inclusiveness and Representation in Clinical Trials
Inclusivity in clinical trials to achieve equitable care.
Common Health Disparities in Women's Health
Derek van Amerongen, MD, MS, drives a panel discussion surrounding disparities currently faced by women in health care.
Payer Considerations in Treatment of RRMM
A panel of multiple myeloma experts discuss costs associated with relapsed/refractory disease.
The RRMM Patient Journey: Part 2
Treatment considerations for relapsing multiple myeloma is discussed by key opinion leaders.
Treatment Landscape Surrounding Atopic Dermatitis
Brian Keegan, MD, PhD, and Michael Cameron, MD, FAAD, describe treatment options for patients with atopic dermatitis.
Patient Journey and Presentations of Atopic Dermatitis
Dr Casey Butrus drives a discussion highlighting typical patient presentations of AD.
